THC Farmaceuticals, Inc. 8-K

What Happened

• THC Farmaceuticals, Inc. filed a Form 8-K on January 30, 2026, announcing that its Board of Directors approved a change in the company’s fiscal year end from September 30 to December 31. The board approved the change on December 31, 2024. The company said this change is intended to better align its reporting with the calendar year and improve comparability of financial reporting and planning.

Key Details

• Board approval date: December 31, 2024.
• Filing date of Form 8-K: January 30, 2026 (Accession No. 0001096906-26-000171).
• New fiscal year end: December 31 (previously September 30).
• The company will file any required transition reports for the short fiscal period created; no amendment to the Articles of Incorporation or Bylaws was required.

Why It Matters

• For investors, the fiscal year change affects the company’s reporting calendar and the timing of periodic reports (annual and quarterly filings).
• The short transition period may lead to an additional set of financial statements for the shortened reporting period, which investors should watch for when comparing year-over-year results.
• Aligning to a calendar-year fiscal year can make it easier to compare THC Farmaceuticals’ results with peers and industry schedules.